Advertisement

A De Novo Variant in Galactose-1-P Uridylyltransferase (GALT) Leading to Classic Galactosemia

  • Thanh-Thanh (Claire) V. Tran
  • Ying Liu
  • Michael E. Zwick
  • Dhanya Ramachandran
  • David J. Cutler
  • Xiaoping Huang
  • Gerard T. Berry
  • Judith L. Fridovich-KeilEmail author
Research Report
Part of the JIMD Reports book series (JIMD, volume 19)

Abstract

Classic galactosemia (CG) is a potentially lethal genetic disease that results from profound impairment of galactose-1-P uridylyltransferase (GALT), the middle enzyme in the Leloir pathway of galactose metabolism. Patients with CG carry pathogenic loss-of-function mutations in both of their GALT alleles; the parents of patients are considered obligate carriers. We report here a first exception to that rule – a de novo GALT variant in a patient with classic galactosemia. The new variant, c.563A>C (p.Q188P), which introduces a missense substitution near the active site of the GALT enzyme, was found in the compound heterozygous state in a child with classic galactosemia, but not in either of her parents. Extensive genomic studies of DNA from the child and both parents confirmed the expected degrees of relationship in the trio as well as inheritance of a common c.563A>G (p.Q188R) GALT mutation from the mother. This result demonstrates that not all pathogenic GALT mutations are inherited and raises concern that GALT may have a higher new mutation rate than previously believed.

Keywords

Dideoxy Sequencing Classic Galactosemia Leloir Pathway Compound Heterozygous State GALT Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

We are especially grateful to the family who participated in this research study; without them none of this work would have been possible. We also thank the Emory Integrated Genomics Core who conducted the Affymetrix genotyping reported here. This work was supported in part by funds from NIH R01 DK059904 (PI: JLFK); DR was supported in part by funds from a training grant in Human Disease Genetics 1T32MH087977 (PI: ST Warren).

References

  1. Boutron A, Marabotti A, Facchiano A et al (2012) Mutation spectrum in the French cohort of galactosemic patients and structural simulation of 27 novel missense variations. Mol Genet Metab 107:438–447CrossRefPubMedGoogle Scholar
  2. Calderon F, Phansalkar A, Crockett D, Miller M, Mao R (2007) Mutation database for the galactose-1-phosphate uridyltransferase (<I>GALT</I>) gene. Hum Mutat 28:939–943CrossRefPubMedGoogle Scholar
  3. Coffee B, Hjelm L, DeLorenzo A, Courtney E, Yu C, Muralidharan K (2006) Characterization of an unusual deletion of the galactose-1-phosphate uridyl transferase (GALT) gene. Genet Med 8:635–640CrossRefPubMedGoogle Scholar
  4. Eiken H, Knappskog P, Apold J, Skjelkvåle L, Boman H (1992) A de novo phenylketonuria mutation: ATG (met) to ATA (ile) in the start codon of the phenylalanine hydroxylase gene. Hum Mutat 1:388–391CrossRefPubMedGoogle Scholar
  5. Fridovich-Keil JL, Walter JH (2008) Galactosemia. In: Valle D, Beaudet A, Vogelstein B, Kinzler K, Antonarakis S, Ballabio A (eds) The online metabolic & molecular bases of inherited disease. McGraw Hill, New York, http://www.ommbid.com/ Google Scholar
  6. Gort L, Boleda M, Tyfield L et al (2006) Mutational spectrum of classical galactosaemia in Spain and Portugal. JIMD 29:739–742Google Scholar
  7. Henderson H, Leisegang F, Brown R, Eley B (2002) The clinical and molecular spectrum of galactosemia in patients from the Cape Town region of South Africa. BMC Pediatr 2:7PubMedCentralCrossRefPubMedGoogle Scholar
  8. Lukac-Bajalo J, Kuzelicki NK, Zitnik IP, Mencej S, Battelino T (2007) Higher frequency of the galactose-1-phosphate uridyl transferase gene K285N mutation in the Slovenian population. Clin Biochem 40:414–415CrossRefPubMedGoogle Scholar
  9. Papachristoforou R, Petrou P, Sawyer H, Williams M, Drousiotou A (2014) A novel large deletion encompassing the whole of the galactose-1-phosphate uridyltransferase (GALT) gene and extending into the adjacent interleukin 11 receptor alpha (IL11RA) gene causes classic galactosemia associated with additional phenotypic abnormalities. JIMD Rep 12:91–98PubMedCentralCrossRefPubMedGoogle Scholar
  10. Pyhtila B, Shaw K, Neumann S, Fridovich-Keil J (2014) Newborn screening for galactosemia in the United States: looking back, looking around, and looking ahead. JIMD RepGoogle Scholar
  11. Tyfield L, Reichardt J, Fridovich-Keil J et al (1999) Classical galactosemia and mutations at the galactose-1-phosphate uridyl transferase (GALT) gene. Hum Mutat 13:417–430CrossRefPubMedGoogle Scholar
  12. White M, Leppert M, Nielsen D et al (1991) A de novo cystic fibrosis mutation: CGA (Arg) to TGA (stop) at codon 851 of the CFTR gene. Genomics 11:778–779CrossRefPubMedGoogle Scholar

Copyright information

© SSIEM and Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Thanh-Thanh (Claire) V. Tran
    • 1
  • Ying Liu
    • 2
  • Michael E. Zwick
    • 2
  • Dhanya Ramachandran
    • 2
  • David J. Cutler
    • 2
  • Xiaoping Huang
    • 3
  • Gerard T. Berry
    • 3
  • Judith L. Fridovich-Keil
    • 2
    Email author
  1. 1.Biology DepartmentEmory College, Emory UniversityAtlantaUSA
  2. 2.Department of Human GeneticsEmory University School of MedicineAtlantaUSA
  3. 3.The Manton Center for Orphan Disease Research, Division of Genetics and Genomics, Department of PediatricsBoston Children’s Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations